Does BROLUCIZUMAB-DBLL Cause Ocular hyperaemia? 158 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 158 reports of Ocular hyperaemia have been filed in association with BROLUCIZUMAB-DBLL. This represents 5.6% of all adverse event reports for BROLUCIZUMAB-DBLL.
158
Reports of Ocular hyperaemia with BROLUCIZUMAB-DBLL
5.6%
of all BROLUCIZUMAB-DBLL reports
0
Deaths
13
Hospitalizations
How Dangerous Is Ocular hyperaemia From BROLUCIZUMAB-DBLL?
Of the 158 reports, 13 (8.2%) required hospitalization.
Is Ocular hyperaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROLUCIZUMAB-DBLL. However, 158 reports have been filed with the FAERS database.
What Other Side Effects Does BROLUCIZUMAB-DBLL Cause?
Vitreous floaters (479)
Visual impairment (446)
Vision blurred (416)
Eye inflammation (387)
Visual acuity reduced (365)
Retinal vasculitis (323)
Uveitis (305)
Vitritis (284)
Eye pain (234)
Vitreous opacities (205)
What Other Drugs Cause Ocular hyperaemia?
DUPILUMAB (6,938)
CYCLOSPORINE (1,508)
BIMATOPROST (1,447)
CENEGERMIN-BKBJ (1,226)
BRIMONIDINE (917)
ADALIMUMAB (714)
LATANOPROST (587)
DORZOLAMIDE\TIMOLOL (581)
LIFITEGRAST (570)
TRAVOPROST (478)
Which BROLUCIZUMAB-DBLL Alternatives Have Lower Ocular hyperaemia Risk?
BROLUCIZUMAB-DBLL vs BROMAZEPAM
BROLUCIZUMAB-DBLL vs BROMFENAC
BROLUCIZUMAB-DBLL vs BROMHEXINE
BROLUCIZUMAB-DBLL vs BROMOCRIPTINE
BROLUCIZUMAB-DBLL vs BROTIZOLAM